2/23 FGIN-1-27 is an agonist at the translocator protein 18 kDa (TSPO), a cholesterol transporter that is 1 associated with neurosteroidogenesis. This protein has been identified as a peripheral binding site 2 for benzodiazepines; in anamniotes, however, a second TSPO isoform that is absent in amniotes has 3 been implicated in erythropoiesis. Functional conservation of the central benzodiazepine-binding 4 site located in the GABA A receptors has been demonstrated in anamniotes and amniotes alike; 5 however, it was not previously demonstrated for TSPO. The present investigation explored the 6 behavioral effects of FGIN-1-27 on an anxiety test in zebrafish (Danio rerio, Family: Cyprinide) 7 and on a mixed anxiety/panic test on wall lizards (Tropidurus oreadicus, Family: Tropiduridae). 8 Results showed that FGIN-1-27 reduced anxiety-like behavior in the zebrafish light/dark preference 9 test similar to diazepam, but with fewer sedative effects. Similarly, FGIN-1-27 also reduced 10 anxiety-and fear-like behaviors in the defense test battery in wall lizards, again producing fewer 11 sedative-like effects than diazepam; the benzodiazepine was also unable to reduce fear-like 12 behaviors in this species. These results A) underline the functional conservation of TSPO in 13 defensive behavior in anamniotes; B) strengthen the proposal of using anamniote behavior as 14 models in behavioral pharmacology; and C) suggest TSPO/neurosteroidogenesis as a target in 15 treating anxiety disorders.
1. Introduction 19 The translocator protein 18 kDa (TSPO, mitochondrial benzodiazepine receptor [MBR] , peripheral 20 benzodiazepine receptor) was first identified as a peripheral binding site for diazepam, but later 21 identified as part of the mitochondrial cholesterol transport pathway that is associated with the 22 regulation of cellular proliferation, immunomodulation, porphyrin transport and heme biosynthesis, 23 anion transport, regulation of steroidogenesis, and apoptosis (Casellas et al., 2002) . This transporter 24 is highly expressed in steroidogenic tissues. In the central nervous system, its expression is mainly 25 restricted to ependymal cells and glia, in which it is responsible for the local synthesis of 26 neuroactive steroids such as allopregnanolone (Papadopoulos et al., 2006) . This latter neurosteroid, 27 in its turn, positively modulates GABA A receptors, especially those involved in tonic inhibition 28 (Smith et al., 2009; Maguire et al., 2012) , producing anxiolytic-(Fernández-Guasti and Picazo, , 2007, 2009) , and modulates panic attacks (Bali and Jaggi, 2014; Lovick, 2014) . As such, TSPO 1 has been proposed as a pharmacological target for the treatment of neurological and psychiatric 2 disorders associated with decreased GABAergic tone, such as anxiety disorders (Romeo et al., 3 1993; de Mateos-Verchere et al., 1998; Kita et al., 2004; Costa et al., 2011; Matsuda et al., 2011; 4 Nin et al., 2011; Pinna and Rasmusson, 2012; Pinna and Rasmusson, 2012; Perna et al., 2014) and 5 epilepsy (Ugale et al., 2004) , as well as for the fine control of stress responses (Gunn et al., 2011; 6 Maguire et al., 2012; Maguire, 2014) . TSPO agonists produce anti-anxiety and anti-conflict effects 7 in rodents with both systemic (Kita et al., 2004; Costa et al., 2011) and intra-hippocampal (Bitran et 8 al. 2000) injections; these effects are blocked by GABA A receptor antagonists (i.e. picrotoxin) 9 and/or 5α-reductase blockers (i.e. 4-MA) and TSPO antagonists (PK 11195), implicating 10 neurosteroidogenesis and chloride ion channel at the GABA A receptors in these responses (Bitran et 11 al. 2000) . Additionally, octadecaneuropeptide, a diazepam-binding inhibitor peptide that acts 12 through both the central benzodiazepine receptor (CBR) and TSPO produces anxiety-like behavior 13 in mice and rats (de Mateos-Verchere et al., 1998) , as well as in goldfish (Matsuda et al., 2011) . 14 These effects are spared in adrenalectomized and castrated animals, suggesting that they are not 15 mediated by peripheral steroidogenesis, but rather by the production of neurosteroids in the brain 16 (Romeo et al., 1993) . 17 TSPO is highly conserved, being present in Bacteria, Archaea and Eukarya domains (Fan 18 and Papadopoulos, 2013). Anamniotes and invertebrates possess a single isoform, while amniotes 19 possess two TSPO isoforms (Fan et al., 2009) . Interestingly, while no functional divergence is 20 predicted to appear between tspo (found in invertebrates and basal vertebrates) and tspo1 (found in 21 amniotes), a functional divergence was detected in TSPO2 (Fan and Papadopoulos, 2013) . Some of 22 the neurobehavioral functions of this protein, on the other hand, seem to be conserved. In zebrafish, 23 for example, benzodiazepines have been shown to affect a plethora of anxiety-like behaviors, from 24 bottom-dwelling (Bencan et al., 2009; Egan et al., 2009) and dark preference (Maximino et al., 25 4/23 2010 , 2011 ) to shoal cohesion (Gebauer et al., 2011 and cocaine withdrawal-induced anxiety-like 1 behavior (López-Patiño et al., 2008) . Likewise, benzodiazepines decrease tonic immobility duration 2 and the following freezing and explosive behavior in a defensive behavior battery in the wall lizard 3 (Tropidurus oreadicus), and also increase exploratory behavior in the same test (Maximino et al., 4 2014). In the separation stress paradigm, benzodiazepines attenuate separation stress-induced 5 distress vocalizations in chicks in the anxiety phase, but not in the depression phase (Warnick et al., 6 2009). Thus, agonists at the CBR decrease fear-and anxiety-like behavior in both amniotes and 7 anamniotes. Moreover, some evidence regarding the neurosteroidogenesis pathway in behavioral 8 control has been suggested by the observation that allopregnanolone has an anticonvulsant effect in 9 zebrafish (Baxendale et al. 2012) , and that chronic fluoxetine treatment upregulates the expression 10 of genes from the neurosteroidogenesis pathway in this species (Wong et al. 2013 or two drops of Tween 80 was added before sonication into a fine suspension (Auta et al. 1993) . The adult zebrafish were assigned to 12 independent groups (n= 10 fish per group): a vehicle group 19 (propylene glycol:ethyl alcohol:sodium benzoate:benzyl alcohol for the diazepam controls, DSMO 20 for the FGIN-1-27 controls) that received 1 µL/0.1 g b.w.; and 10 additional groups that received 21 the doses described above for diazepam (5 groups) or FGIN-1-27 (5 groups). Sample sizes were 22 based on Maximino et al. (2010) . All drugs were i.p. injected in a volume of 1 µL/0.1 g b.w., 30 23 min before of the behavioral test. Animals were randomly drawn from the holding tank immediately 24 before injection, and the order with which doses were tested was randomized via generation of 25 random numbers using the randomization tool in http://www.randomization.com/. Experimenters 26 6/23 were blinded to treatment by using coded vials for drugs. The data analyst was blinded to phenotype 1 by using coding to reflect treatments in the resulting datasets; after analysis, data was unblinded. Number of risk assessment: defined as a fast (<1 s) entry in the white compartment followed by 2 re-entry in the black compartment, or as a partial entry in the white compartment (i.e., the 3 pectoral fin does not cross the midline); 4 A digital video camera (Samsung ES68, Carl Zeiss lens) was installed above the apparatus to record 5 the behavioral activity of the zebrafish. Two independent observers, blinded to treatment, manually 6 measured the behavioral variables using X-Plo-Rat 2005 (https://github.com/lanec-unifesspa/x-plo-7 rat). Inter-observer reliability was at least > 0.85. The data were analyzed using two-way ANOVAs, with drug and dose as between-subjects factors.
Experiment 1: Effects of FGIN-1-27 and diazepam on dark preference in zebrafish

11
Values of p ≤ 0.05 in the ANOVA were followed by Tukey's HSD whenever appropriate; planned 12 comparisons were between different doses of a given drug and its vehicle and between same doses 13 of both drugs. All statistical analyses were made using R 3. Adult lizards were assigned to 12 independent groups (n= 10 lizards per group): a vehicle group 25 9/23 (propylene glycol:ethyl alcohol:sodium benzoate:benzyl alcohol for the diazepam controls, DSMO 1 for the FGIN-1-27 controls) that received 1 µL/0.1 g b.w.; and 10 additional groups that received 2 the doses described above for diazepam (5 groups) or FGIN-1-27 (5 groups). Sample sizes were 3 based on Maximino et al. (2014) . All drugs were i.p. injected in a volume of 0.5 ml per animal, 30 4 min before of the behavioral test. Animals were randomly drawn from the cage immediately before 5 injection, and the order with which doses were tested was randomized via generation of random 6 numbers using the randomization tool in http://www.randomization.com/. Experimenters were 7 blinded to treatment by using coded vials for drugs. The data analyst was blinded to phenotype by 8 using coding to reflect treatments in the resulting datasets; after analysis, data was unblinded. The defense test battery was applied as described by Maximino et al. (2014) . Briefly, tonic The data were analyzed using two-way ANOVAs, with drug and dose as between-subjects factors. 16 Values of p ≤ 0.05 in the ANOVA were followed by Tukey's HSD whenever appropriate; planned 17 comparisons were between different doses of a given drug and its vehicle and between same doses 18 of both drugs. All statistical analyses were made using R 3. an interaction effect (F 5,107 = 4.939, p = 0.000416) were observed in time spent into the white 5 compartment ( Figure 1A) . Post-hoc tests uncovered differences between all doses except the 6 highest in relation to controls in diazepam-treated animals (p < 0.001) and between all doses in 7 relation to controls in FGIN-1-27-treated animals (p < 0.001). Finally, differences were also 8 observed between FGIN-1-27-and diazepam-treated animals at doses of 0.57 mg/kg (p = 0.0012), 9 1.1 mg/kg (p < 0.0001), and 2.3 mg/kg (p = 0.0002).
10
Main effects of drug (F 1, 107 = 17.64, p < 0.0001) and dose (F 5, 107 = 207.77, p < 0.0001), as well as 11 an interaction effect (F 5, 107 = 20.11, p < 0.0001), were found for risk assessment (Figure 1B) . hoc tests uncovered differences between vehicle-treated and diazepam-treated animals at all doses 13 (p < 0.0001), and between vehicle-treated and FGIN-1-27-treated animals at all doses (p < 0.0001).
14 Moreover, differences between diazepam-and FGIN-1-27-treated animals were observed at 1.1 15 mg/kg (p = 0.012) and 2.3 mg/kg (p < 0.0001).
16
A main effect of dose (F 5, 107 = 111.547, p < 0.0001), but not drug (F 1, 107 = 0.643, p = 0.424), was 17 found for thigmotaxis ( Figure 1C ), and an interaction effect was also found (F 5, 107 = 10.536, p < 18 0.0001). Post-hoc tests unveiled differences between vehicle-treated and diazepam-treated animals 19 at doses above 0.28 mg/kg (p < 0.01), as well as between all FGIN-1-27 doses and vehicle-treated 20 animals (p < 0.0001). Differences were also observed between diazepam-and FGIN-1-27-treated 21 zebrafish at doses of 0.14 mg/kg (p = 0.0065) and 1.1 mg/kg (p = 0.044).
22
Main effects of drug (F 1, 107 = 89.134, p < 0.0001) and dose (F 5, 107 = 47.418, p < 0.0001), as well as 23 an interaction effect (F 5. 107 = 6.921, p < 0.0001), were found for freezing ( Figure 1D ). Post-hoc 24 tests uncovered differences between vehicle-treated and diazepam-treated animals at all doses (p < 25 12/23 0.001), and between FGIN-1-27-treated and vehicle-treated animals at 0.28 mg/kg and higher doses 1 (p < 0.001). Differences were also found between diazepam-and FGIN-1-27-treated zebrafish at 2 doses of 0.14 mg/kg (p = 0.03), 1.1 mg/kg (p < 0.0001), and 2.3 mg/kg (p < 0.0001). 3 Main effects of drug (F 1, 107 = 14.57, p = 0.000226) and dose (F 5, 107 = 42.64, p < 0.0001), as well as 4 an interaction effect (F 5, 107 = 26.48, p < 0.0001), were found for erratic swimming (Figure 1E) . 5 Post-tests uncovered no statistically significant differences between vehicle-treated and diazepam-6 treated animals at any dose (p > 0.05), while FGIN-1-27-treated animals were significantly different 7 between vehicle-treated animals at doses of 0.28 mg/kg (p = 0.0001), 1.1 mg/kg (p < 0.001) and 2.3 8 mg/kg (p < 0.0001). Also, differences were observed between FGIN-1-27-and diazepam-treated 9 animals at 0.28 mg/kg (p = 0.021), 1.1 mg/kg (p = 0.05), and 2.3 mg/kg (p < 0.0001).
10
Finally, no main effects of drug (F 1, 107 = 3.526, p = 0.0631), but a main dose effect (F 5, 107 = 9.088, 11 p < 0.0001) as well as a suggestive interaction effect (F 5, 107 = 2.778, p = 0.0212) were found for 12 number of transitions into the white compartment ( Figure 1F ). Post-hoc tests uncovered differences Main effects of drug (F 1, 108 = 248.5, p < 0.0001) and dose (F 1, 108 = 93.39, p < 0.0001), as well as an 19 interaction effect (F 1, 108 = 60.09, p < 0.0001) were found for TI duration (Figure 2A) . Post-hoc tests 20 found statistically significant differences between vehicle-and diazepam-treated lizards at doses of an interaction effect (F 5, 108 = 66.98, p < 0.0001) were found for circling behavior (Figure 2B ). Post-1 hoc tests revealed differences between vehicle-and FGIN-1-27 treated lizards at all doses (p < 2 0.0001), and between vehicle-and diazepam-treated animals at 1.1 and 2.3 mg/kg (p < 0.05). 3 Differences between diazepam-and FGIN-1-27-treated lizards were also found for all doses (p < 4 0.0001).
5
Main effects of drug (F 1. 108 = 291.58, p < 0.0001) and dose (F 5, 108 = 45.09, p < 0.0001), as well as 6 an interaction effect (F 5, 108 = 14.63, p < 0.0001) were found for freezing ( Figure 2C ). Post-hoc tests 7 identified significant differences between vehicle-and diazepam-treated animals at 1.1 mg/kg (p < 8 0.0001) and between vehicle-and FGIN-1-27-treated animals at all doses (p < 0.0001). Differences 9 between diazepam-and FGIN-1-27-treated lizards were also found for all doses (p < 0.0001).
10
A drug main effect (F 1, 108 = 1487.5, p < 0.0001) and a dose main effect (F 5, 108 = 110.54, p < 11 0.0001), as well as an interaction effect (F 5. 108 = 86.71, p < 0.0001) were observed for ventilatory 12 frequency ( Figure 2D ). Post-hoc tests uncovered differences between vehicle-and diazepam-treated 13 animals at 1.1 mg/kg (p < 0.0001), and between vehicle-and FGIN-1-27-treated animals at all 14 doses (p < 0.0001). Finally, statistically significant differences were found between diazepam-and 15 FGIN-1-27-treated animals at all doses (p < 0.0001). 16 Main effects of drug (F 1, 108 = 34.26, p < 0.0001) and dose (F 5, 108 = 413.3, p < 0.0001), as well as 17 interaction effect (F 5, 108 = 351.08, p < 0.0001) were found for tongue-flicking ( Figure 2E ). Post-hoc 18 tests revealed significant differences between vehicle-and diazepam-treated lizards at doses of 1.1 19 and 2.3 mg/kg (p < 0.0001), and between vehicle-and FGIN-1-27-treated lizards at all doses except 20 the highest (p < 0.0001). Moreover, statistically significant differences between diazepam-and 21 FGIN-1-27-treated lizards at all evaluated doses were found (p < 0.0001).
22
Main effects of both drug (F 1, 108 = 91.53, p < 0.0001) and dose (F 5, 108 = 36.28, p < 0.0001), as well 23 as an interaction effect (F 5, 108 = 56.62, p < 0.0001) were found for total locomotion ( Figure 2F ).
24
Significant differences were found between vehicle-and diazepam-treated lizards at 0.57 and 2.3 25 14/23 mg/kg (p < 0.0003) and vehicle-and FGIN-1-27-treated lizards at 1.1 and 2.3 mg/kg (p < 0.002).
1 Finally, statistically significant differences were also found between diazepam-and FGIN-1-27-2 treated animals at 2.3 mg/kg (p < 0.0001). In the lizard defense test battery, induction of TI produces a stereotypical behavioral pattern in 16 which is followed by either freezing or "explosive" circling behavior; after that, the animal emits 17 exploratory behavior, marked by thigmotaxis ("wall-hugging") and tongue-flicking ( been presumably associated to sedative actions (Auta et al., 1993) , which coincides with our 25 16/23 findings that diazepam and FGIN-1-27 produced anxiolytic-like effects, with locomotor-impairing 1 effects at the highest dose. Although anxiolytic-like and locomotor effects differ between diazepam 2 and FGIN-1-27 in this work, contrast in the pharmacological profile (i.e. anxiolytic, anticonvulsant, 3 and sedative) between these drugs has been previously reported (Okuyama et al., 1999; Auta el al., 4 2003) . It has been suggested that in addition to the effects on TSPO, FGIN-1-27 also acts indirectly 5 on the GABA A receptor by facilitating production of neurosteroids that bind to the receptor. 6 Neurosteroids have an specific binding domain in GABA A receptor, through which they can 7 produce anxiolytic effects (Enna, 2007) , whereas diazepam binds to the benzodiazepine binding 8 domain of GABA (that is, the CBR). In brief, although FGIN-1-27 and diazepam might act on the 9 same receptor they do it through different binding domains (Romeo et al., 1992) , which could 10 explain the minute variations in the effects of diazepam and FGIN-1-27 in zebrafish. For example, 11 in rodents the anxiolytic effects of benzodiazepines, but not of FGIN-1-27, are antagonized by 12 flumazenil (Auta et al., 1993) . Additionally, there is still the possibility that neuroesteroids 13 increased trough FGIN could be acting through a different system than the GABAergic, a 14 possibility that remains to be explored. 
